. Verification: 8ea7dd8e8067cf6e

Is Beyfortus Putting Newborns at Risk? – RSV Vaccine Safety Alert

The drama unfolds as infants contemplate forming picket lines outside maternity wards, wielding tiny protest signs that read, "Down with Beyfortus!" The uproar arises not from bedtime squabbles or demands for extra milk but from a heated debate swirling around a vaccine's safety. Are we witnessing the birth of a revolution in newborns' rights?

RSV Vaccine Safety Alert: Unprecedented Rise in Newborn Deaths Raises Concerns

The safety of newborns receiving RSV vaccines has been brought into question following a troubling surge in infant deaths. This alarming discovery coincides with the introduction of Beyfortus, a monoclonal antibody treatment for respiratory syncytial virus (RSV) in newborns. As concerns escalate, experts shed light on concerning safety signals and the lack of extensive studies.

Unprecedented Safety Signals: French Researchers Express Alarm

French independent scientist Hélène Banoun, Ph.D., and statistician Christine Mackoi uncovered unsettling data from France's National Institute of Statistics and Economic Studies (INSEE), revealing an unexpected increase in newborn deaths between 2 to 6 days old during September and October 2023, coinciding with Beyfortus's introduction.

Coincidence or Cause? Beyfortus Rollout and Infant Mortality

The rollout of Beyfortus in French hospitals began on Sept. 15, 2023. Concerningly, over 200,000 newborns received the injection since then. This introduction aligns with the rise in infant deaths, raising questions about the correlation between Beyfortus administration and the surge in mortality rates.

Lack of Comprehensive Studies Raises Red Flags

Medical experts, including Dr. Meryl Nass and cardiologist Peter McCullough, emphasize the absence of long-term studies involving Beyfortus and newborns. Highlighting the unprecedented nature of monoclonal antibody administration in this population, experts urge caution due to limited data on RSV's actual risk to babies.

Alarming Data: Abnormal Increase in Newborn Deaths

Analysis of INSEE data by Mackoi indicates a 50% increase in deaths among babies aged 2 to 6 days compared to expected rates. This surge in mortality, significantly higher than historical averages, aligns suspiciously withh Beyfortus injections.

Safety Concerns and Adverse Reactions

Reports from the French National Authority for Health (HAS) outline adverse reactions following Beyfortus injections, contradicting claims of its efficacy. Concerningly, adverse events, including bronchiolitis, have been reported despite the drug's intended purpose to protect against respiratory illnesses.

Censorship and Regulatory Oversight

Despite these concerning signals, responses from public health authorities have been lacking. Criticisms and discussions from experts like Banoun have been met with censorship, raising questions about the transparency and openness of discussions surrounding vaccine safety.

Financial Interests and Liability Concerns

Experts warn of financial interests driving the promotion of Beyfortus and potentially extending liability shields to pharmaceutical companies. The market potential for bronchiolitis prevention raises ethical concerns about prioritizing financial gains over genuine safety evaluations.

Parental Caution Advised

Amidst these revelations, experts advise caution to parents and physicians, recommending a conservative approach when considering Beyfortus for newborns. Expectant mothers are encouraged to be prepared and informed, resisting undue pressure in hospitals to administer the drug.

In light of these safety concerns and the lack of comprehensive studies, a critical reevaluation of Beyfortus's widespread administration to newborns is imperative to ensure the safety and well-being of infants.

Free Speech and Alternative Media are under attack by the Deep State. Real Raw News needs reader support to survive and thrive. 

Please do not give your hard-earned money to sites or channels that copy/paste our intellectual property. We spend countless hours vetting, researching, and writing. Thank you. Every dollar helps. Contributions help keep the site active and help support the author (and his medical bills)

Contribute to Real Raw News via  GoGetFunding

 

 

 

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top